ProCE Banner Series

Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea

Join these live, expert-led workshops for updates on the latest strategies for optimal management of chorea in patients with Huntington’s disease. Topics include communication with patients and caregivers, integration of various specialists into interdisciplinary care teams, and individualizing treatment decisions with the availability of novel agents.

  AMA
Who Should Attend

This program is intended for healthcare professionals who care for patients with HD, including neurologists, movement disorder specialists, and those in primary care who see patients with HD. 

All Events

Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea

Upcoming Events

September

25

2024

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

New York, New York

Faculty

ProCE Banner Faculty
Victor W. Sung, MD

Professor
Department of Neurology
Division of Movement Disorders
Clinic Director
Huntington's Disease Clinic/HDSA Center of Excellence
University of Alabama at Birmingham
Birmingham, Alabama

Topics

Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Huntington Disease (HD).

Target Audience
This program is intended for healthcare professionals who care for patients with HD, including neurologists, movement disorder specialists, and those in primary care who see patients with HD. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify strategies for improving identification of and management of HD and chorea
  • Incorporate communication strategies and shared decision-making into care plans to address the impact of chorea on patients and caregivers
  • Assess evidence for efficacy and safety profiles of newer agents used in the treatment of HD chorea
  • Construct a patient care plan that integrates novel agents into the current treatment of HD chorea

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Topsy Turvy Treatment: A Case-Based Exploration of Huntington’s Chorea has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Neurocrine Biosciences, Inc.